The FDA approval of pritelivir offers an oral treatment for refractory HSV lesions in immunocompromised adults, with drug interactions creating an important role for pharmacists.
Publication|Articles|January 1, 2025
- Optimizing Delivery of Nimodipine in Patients With Subarachnoid Hemorrhage
Optimizing Delivery of Nimodipine in Patients With Subarachnoid Hemorrhage
Author(s)Azurity Pharmaceuticals
Key Takeaways
- Personalized treatment strategies are crucial in managing lung cancer brain metastases, integrating targeted therapies and immunotherapies for improved outcomes.
- Stereotactic radiosurgery and whole-brain radiotherapy are evolving with novel systemic therapies, offering less invasive options.
This article is sponsored by Azurity Pharmaceuticals, Inc.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
SubscribeAdvertisement
Related to this article
Weltruza, the first subcutaneous long-acting injectable (LAI) formulation of olanzapine, requires no loading doses, oral supplementation, or postinjection monitoring.
Eric Lawitz, MD, explains how pharmacists can raise liver risk with patients with obesity and why a FIB-4 score from routine blood work is a good first step.
Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.
Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.
A float pharmacist reflects on how practicing in different communities revealed that patients often have more in common than they first appear to.
Patients reported that zongertinib resulted in improvements in physical functioning within 1 week of initiating therapy.
As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
2
The Value of Self-Monitoring Blood Glucose Tools in Preventing and Reducing Prediabetes and Diabetes-Related Complications
3
What Different Communities Taught Me About Patient Care
4
Patients Report Early, Sustained Functional Gains With First-Line Zongertinib in HER2-Mutant NSCLC
5